【Event Background】
【Event Highlight】
【Hot Topics / Agenda】
>>【Panel Discussion】Differentiated Innovation: New Cooperation Trend of Biomedical Industry under the Global Pandemic
>>【Panel Discussion】Globalization vs. Localization: Big Pharma's External Innovation Strategy Revolution
>>【Panel Discussion】Accelerating Process: A New Commercialization Journey of Global Innovative Drug Companies
>>【Panel Discussion】License-out Explosion: Key Considerations for New Drugs' Globalization
>>【Panel Discussion】Nothing but Fast: Strategy Construction and Commercial Cooperation of Global Synchronous Clinical Trials
>>【Panel Discussion】China vs. Global: Source Innovation and Business Model Exploration
>>【Panel Discussion】'Licensing-in and Self-develop' :the Differentiated Product Pipeline Layout Strategy
>>【Panel Discussion】Rationality Return: Pharmaceutical Investment New Trend in the Capital Winter
>>【Panel Discussion】IPO 2.0 Era: The IPO and Post-IPO Development of Pharmaceutical Companies Simultaneous
Development of Global New Drugs
>>'Domestic BD': Collaborative Innovation of Chinese Big Pharma and Biotech Companies
>>Clinical Value-oriented: Construction of Pharmaceutical Internationalization Capability
>>Licensing-In and Licensing-Out: The Transformation and Innovation of Traditional Chinese Big Pharma
>>Global Collaborative Innovation:Antibody Drug Development and Global Commercialization
>>Capital Market Insight: M&A and business cooperation trends of pharmaceutical companies
>>Case:Adagene’s Cross-border Deals
>>Case:Open Innovation: Global Cooperation Exploration of Huadong Medicine
>>Case：Strategic Cooperation: MNC Trasaction Practice Sharing
>>Master Class:Global Licensing and Cooperative Trasaction of Pharmaceutical Companies
【Who should attend】
【Outstanding Past Speakers】
【Part of Previous Attending Companies】
